Simethicone as Part of ERAS in Bariatric Surgery Patients
Simethicone as Part of an Enhanced Recovery After Surgery (ERAS) Protocol
Madigan Army Medical Center
260 participants
Apr 8, 2025
INTERVENTIONAL
Conditions
Summary
By conducting this study, we hope to assess if simethicone (also known as Gas Relief or GasX) has an effect on improving gas pain and bloating specifically in patients undergoing foregut procedures to include bariatric procedures (sleeve gastrectomy, Roux-en-Y gastric bypass), hiatal hernia, and gastric surgery. The purpose of this research is to gather information on the safety and effectiveness of simethicone. Simethicone (more commonly known as Gas Relief or Gas-X) relieves pressure, bloating, and fullness commonly referred to as gas. It is FDA approved. The use of this medication in this research study is consistent with labeling indications.
Eligibility
Inclusion Criteria1
- Foregut procedures
Exclusion Criteria4
- Non-foregut procedures
- Allergy to simethicone
- Pregnancy or breastfeeding
- Minors under 18 years of age
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients will receive simethicone 80mg four times per day for 2 weeks post-operatively.
Patients in the control group will receive a placebo pill four times per day for 2 weeks
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06812832